Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Zoetis (ZTS) stood at $146.25, denoting a -1.32% move from the preceding trading day.
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--If approved, Zoetis' Portela will be the first long-acting anti-NGF mAb therapy for cats and is designed to provide 3 months of OA pain rel...
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Zoetis (ZTS) reached $149.79 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.
Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Zoetis Inc. (NYSE:ZTS ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:05 PM EDT Company Participants Kristin Peck - CEO & Director Wetteny Joseph - Executive VP & CFO ...
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
Phibro Animal Health Corporation's Zoetis MFA acquisition has revitalized its overall growth. Animal Health is now around 75% of their total sales, and its integration should be finalized by Q4 202...
Zoetis: A Solid Dividend Growth Investment For The Long Haul
Zoetis is a global leader in animal health with strong organic growth, robust product innovation, and strategic M&A driving long-term revenue and earnings expansion. The company boasts exceptional ...
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 million aggregate pr...
Zoetis CEO: It's unclear if animal health will be a part of pharmaceutical tariffs
Kristin Peck, Zoetis CEO, joins 'Closing Bell: Overtime' to discuss Q2 earnings, tariff impact on business and domestic production.
Here's Why Zoetis (ZTS) Fell More Than Broader Market
In the latest trading session, Zoetis (ZTS) closed at $148.81, marking a -1.46% move from the previous day.
Zoetis (ZTS) Laps the Stock Market: Here's Why
In the most recent trading session, Zoetis (ZTS) closed at $151.19, indicating a +2.59% shift from the previous trading day.
Zoetis: Growth To Continue Thanks To Companion Animals
Zoetis remains a compelling long-term investment, driven by strong growth in companion animal products and a resilient pet care market. Despite recent underperformance and valuation concerns, Zoeti...
Phibro Animal Health: The Animal Is Unleashed
Phibro Animal Health's acquisition of Zoetis' medicated feed additive business has driven significant momentum and improved financial performance. Organic growth and margin expansion is seen across...
Zoetis Stock Rises 13% in a Month: Time to Add to Your Portfolio?
ZTS jumps 13% in a month as strong new product sales, strategic deals, and rising earnings estimates boost investor confidence.
Zoetis Inc. (ZTS) William Blair 45th Annual Growth Stock Conference (Transcript)
Zoetis Inc. (NYSE:ZTS ) William Blair 45th Annual Growth Stock Conference June 3, 2025 11:40 AM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Brandon Vazquez - William B...
Beat the S&P 500 With This Cash-Gushing Dividend Stock
You don't need to uncover the next big artificial intelligence stock to outperform the broader stock market. Sometimes, consistent and profitable growth is all you need to achieve outsize investmen...
Related Companies